International Journal of Hematology and Oncology
2025, Vol 35, Num 1 Page(s): 110-114
Back | Table of Contents | Turkish Abstract | PDF | Mail to Author | |
CUTANEOUS PARANEOPLASTIC SYNDROMES
Başak YALÇIN
Ankara Numune Eğitim ve Araştırma Hastanesi 1. Dermatoloji Kliniği, ANKARA
Keywords: Cutaneous paraneoplastic syndroms, cancer
Paraneoplastic syndromes are remote signs of cancer and might be detected before, during or after the diagnosis of a primary cancer. Identification of paraneoplastic syndromes might be important for early diagnosis and treatment. Since dermatological lesions are easily detactable, these symptom and signs can be the reason for a cancer patient to refer to a physician. “Cutaneous paraneoplastic syndromes” usually follow a paralel course with the underlying malignancy. Cutaneous paraneoplastic syndromes can be classified as disorders of keratinization, pigmentation impairment, neutrophylic dermatoses, endocrine and metabolic lesions, bullous lesions and miscellaneous lesions. In this review the most common cutaneous paraneoplastic syndromes are overviewed.
Başak YALÇIN
Ankara Numune Eğitim ve Araştırma Hastanesi 1. Dermatoloji Kliniği, ANKARA
Keywords: Cutaneous paraneoplastic syndroms, cancer
Paraneoplastic syndromes are remote signs of cancer and might be detected before, during or after the diagnosis of a primary cancer. Identification of paraneoplastic syndromes might be important for early diagnosis and treatment. Since dermatological lesions are easily detactable, these symptom and signs can be the reason for a cancer patient to refer to a physician. “Cutaneous paraneoplastic syndromes” usually follow a paralel course with the underlying malignancy. Cutaneous paraneoplastic syndromes can be classified as disorders of keratinization, pigmentation impairment, neutrophylic dermatoses, endocrine and metabolic lesions, bullous lesions and miscellaneous lesions. In this review the most common cutaneous paraneoplastic syndromes are overviewed.
Back | Table of Contents | Turkish Abstract | PDF | Mail to Author | |